Disclosed are glucagon-like peptide-1 (GLP-1) compounds with modifications at one or more of the following positions: 7, 8, 12, 16, 18, 19, 20, 22, 25, 27, 30, 33, and 37. Methods of treating a subject in need of GLP-1 receptor stimulation using these GLP-1 compounds are also disclosed.

 
Web www.patentalert.com

< Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders

< Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds

> Methods and compositions for treating polycystic ovary syndrome

> Methods and compositions for treating polycystic ovary syndrome
~ 00286